Ming Capital
Overview
Ming Capital is a global healthcare venture capital firm that supports global medical breakthroughs, especially in innovative medicine, medical devices, and IVD.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Wuhan Binhui Biopharmaceutical Co., Ltd. | Apr 2022 | Series B Extension | Co-investor |
| AlloyX | Jan 2025 | Seed | Co-investor |
| Eureka Bio | Apr 2021 | Series A | Co-investor |
| Miracor Medical SA | Sep 2018 | Series D | Lead |
| Caretaker Medical | Jun 2020 | Series B | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Ming Capital based?
Ming Capital is headquartered in Shenzhen, China.
When was Ming Capital founded?
Ming Capital was founded in 2015.
How many portfolio companies does Ming Capital have?
Ming Capital has 5 portfolio companies in Caplight's dataset.
What are some companies in Ming Capital's portfolio?
Portfolio companies visible on Caplight include Wuhan Binhui Biopharmaceutical Co., Ltd., AlloyX, Eureka Bio, Miracor Medical SA, Caretaker Medical.
What was Ming Capital's most recent investment shown here?
Ming Capital's most recent investment in this portfolio sample was in AlloyX in 2025.
What sectors does Ming Capital focus on?
Ming Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Crypto & Web3, FinTech, Frontier & Industrial Tech.
What company stages does Ming Capital focus on?
Ming Capital typically invests at the Late stage.